IL2 and melanoma: 1. Recent improvements in adjuvant systems (e.g., CpG-loaded vaccines) enhance T cell activation and improve efficacy [26]. 2. Peptide vaccines have shown efficacy when used with other therapies like IL-2, improving survival in melanoma patients [28]